Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our
treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
THIS IS VERY INTERESTING! CLINICAL RESEARCHERS, SCIENTISTS, AND DOCTORS HAVE BEEN DEBATING WHICH TYPE OF STEM CELL WORKS BEST FOR A VARIETY OF CONDITIONS INCLUDING HEART FAILURE. AS FAR AS I KNOW, NOBODY CAN SAY FOR CERTAIN WHICH POPULATION OF STEM CELLS ARE MORE EFFECTIVE. ARE THE ADULT BONE MARROW DERIVED MONONUCLEAR BETTER FOR THE HEART? ARE THE ADULT MESENCHYMAL STEM CELLS BETTER FOR HEART FAILURE? OR IS IT A COMBINATION OF THE TWO THAT IS BEST? I DON'T KNOW, BUT THIS TRIAL SEEMS TO BE A STEP IN THE RIGHT DIRECTION TO FIND OUT:
B
ioCardia, Inc., a regenerative medicine company, and the University of Miami today announced that the United States Food and Drug Administration approved a clinical investigation of two adult stem cell populations in the setting of heart failure. This groundbreaking study will take place at the University of Miami Miller School of Medicine. This is the first stem cell trial comparing two cell populations. The two investigational cell populations to be studied include autologous adult bone marrow derived mononuclear cells and adult autologous mesenchymal cells. These cell populations have excellent safety profiles (NOT ONLY EXCELLENT SAFETY PROFILES, THEY BOTH HAVE EXCELLENT EFFICACY PROFILES AS WELL- DM) in clinical studies performed to date. As cells are taken from the patient's own bone marrow, there will be no issues of rejection of the cells as foreign by the patient's immune system.CLICK HERE TO READ THE FULL ARTICLE